Shelley Berkley Probed Over Kidney Program

By JTA

Published July 10, 2012.
  • Print
  • Share Share

The U.S. House of Representatives Ethics Committee launched an investigation into pro-Israel Rep. Shelley Berkley (D-Nev.), potentially complicating her bid for the U.S. Senate.

Rep. Shelley Berkley
getty images
Rep. Shelley Berkley

The investigation announced Monday, and backed by both Democrats and Republicans on the committee, will focus on allegations that Berkley’s championing of kidney care benefitted her husband, a leading kidney specialist in Nevada.

“The Committee notes that the mere fact of establishing an investigative subcommittee does not itself indicate that any violation has occurred,” said a statement from the Ethics Committee.

Berkley’s office said she was “pleased with the committee’s decision to conduct a full and fair investigation, which will ensure all the facts are reviewed.”

Berkley’s successful efforts to block a federal bid to close a kidney transplant center saved part of a practice her husband co-owns.

Berkley, widely considered as among the most pro-Israel members of the House, was seen as one of a handful of chances for the Democrats to pick up a Senate seat in a year when they are defending most of their seats. She faces Sen. Dean Heller (R-Nev.) who was named to the seat after Sen. John Ensign (R-Nev.) resigned in a scandal.


  • Print
  • Share Share

The Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, the Forward requires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, the Forward reserves the right to remove comments for any reason.






    Would you like to receive updates about new stories?














    We will not share your e-mail address or other personal information.

    Already subscribed? Manage your subscription.